Document ID: chunk:federal_register_of_legislation:F2019C00013:reg:9
Version: federal_register_of_legislation:F2019C00013
Segment Type: reg
Provision Reference: reg 9
Character Range: 5480–8024

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting sarcoidosis or death from sarcoidosis with the circumstances of a person's relevant service:
(1)          being treated with a drug from a class of drugs from the specified list of drugs within the five years before the clinical onset of sarcoidosis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(1a) having immunotherapy for cancer or targeted therapy for cancer within the five years before the clinical onset of sarcoidosis;
Note: immunotherapy for cancer and targeted therapy for cancer are defined in the Schedule 1 - Dictionary.
(2)          being treated for human immunodeficiency virus infection with antiretroviral drugs at the time of the clinical onset of sarcoidosis;
(3)          being treated with a tumour necrosis factor-α inhibitor at the time of the clinical onset of sarcoidosis;
         (3a) having a malignant neoplasm in the ten years before the clinical onset of sarcoidosis;
(4)          being obese for at least five years within the 20 years before the clinical onset of sarcoidosis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(5)          having received an organ or tissue transplant from a donor with sarcoidosis within the two years before the clinical onset of sarcoidosis;
(6)          being treated with a drug from a class of drugs from the specified list of drugs within the five years before the clinical worsening of sarcoidosis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(6a) having immunotherapy for cancer or targeted therapy for cancer within the five years before the clinical worsening of sarcoidosis;
Note: immunotherapy for cancer and targeted therapy for cancer are defined in the Schedule 1 - Dictionary.
(7)          being treated for human immunodeficiency virus infection with antiretroviral drugs at the time of the clinical worsening of sarcoidosis;
(8)          being treated with a tumour necrosis factor-α inhibitor at the time of the clinical worsening of sarcoidosis;
         (8a) having a malignant neoplasm in the ten years before the clinical worsening of sarcoidosis;
(9)          being obese for at least five years within the 20 years before the clinical worsening of sarcoidosis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(10)      inability to obtain appropriate clinical management for sarcoidosis.